• Service
  • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • CER
  • About
Subscribe

Our Services

Strategy Consulting

  • Market Entry Strategy
  • Regulatory Strategy
  • Clinical Strategy
  • China Localization Strategy
  • Hainan Urgent Use Pathway
  • Innovation Pathway
  • Fast Track Pathway
  • Digital Health Consulting

Registration Affairs

  • Pre-market Registration
  • Modification Registration
  • Renewal Registration
  • Request for Classification
  • Legal Agent Representation
  • NMPA Expert Panel Meeting
  • NMPA Supplemental Notice

Quality Assurance

  • Postmarket Surveillance Compliance (IFU, Label, GSP)
  • Adverse Event Reporting
  • Recall Handling
  • Periodic Risk Evaluation Report
  • Annual QMS Self-Inspection Report
  • NMPA Inspections & Mock-Audit
  • QMS Establishment/Audit/Remediation
  • QA Gap Analysis
  • Factory Audit
  • Unique Device Identifier

Device Testing

  • China Local Type Testing
  • Device Modification Compliance Testing
  • Biocompatibility Testing
  • EMC Testing

Clinical Research Organization (CRO)

  • Clinical Trials/Research
  • Real-World Study
  • China CER & MDR CER
  • Clinical Evaluation Feasibility Assessment

Customized Training

  • China Regulatory Training
  • China QMS Training
  • China GCP Training
  • China Localization Training
  • Periodic Regulatory Updates Training

Other Services

  • Translation
  • Patent & Trademark
  • Distributor Evaluation & Audit
  • KOL Interview/Consultation
  • Investment
  • Global regulatory services
  • Service
  • Resources
    • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • About
  • CER
  • Subscribe
  • CN
  • US
  • Home
  • News
  • Regulations & Guidelines

News


  • Moments
  • Regulations & Guidelines
  • Fast Track Update
  • QMS/PMS
  • Other News
  • NMPA Monthly Newsletter
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021

NMPA Facilitates The Usage Of Medical Device Master Files

2023-01-31

The NMPA issued a notice on further clarifying matters related to the registration and use of the master…

China NMPA Newsletter – December 2022

2023-01-30

Featured Articles NMPA New Approvals in December 2022 In December 2022, NMPA approved 339 medical devices, including 37…

The Ministry Of Finance Of China Reduces Tariffs On Imported Medical Devices

2023-01-28

To protect human health and reduce patients’ economic burden, the Ministry of Finance of the People’s Republic of…

NMPA CMDE Annual Report For Year 2022

2023-01-20

The Center For Medical Device Evaluation of NMPA (NMPA CMDE for short) has made a summary of the…

NMPA Adjusting Registration Application Payment Terms

2023-01-12

NMPA issued a notice on the deferment of payment of registration review fees for drugs and medical device…

NMPA New Approvals In December 2022

2023-01-10

In December 2022, NMPA approved 339 medical devices, including 37 Class III imported products, 25 Class II imported…

NMPA Collects Public Comments On Guidelines For Registration Review Of Implantable Medical Device Battery

2023-01-05

In order to standardize the requirements for technical review and guide the registration and application of enterprises, CMDE…

NMPA New Approvals In November 2022

2023-01-03

In November 2022, NMPA approved 172 medical devices, including 22 Class III imported products, 29 Class II imported…

China NMPA Newsletter – November 2022

2022-12-28

Featured Articles Seize Golden Chance To Facilitate Your Market Access To China: Shanghai Launched Several Favorable Measures For…

NMPA Encouraging Enterprises To Lead Standard Drafting

2022-12-28

According to the work deployment of the NMPA, the Center for Medical Device Standardization Administration NMPA has drafted…

FDA Approvals In Nov 1-10, 2022

2022-12-16

FDA Decision DataProductManufacturer11/1/2022System, Test, Automated Blood Grouping And Antibody: DG Gel 8 NeutralDiagnostic Grifols, S. A.11/1/2022Pose™ Health Care…

China Starts Implementing The Third Batch Of Medical Device UDI

2022-12-16

NMPA issued the Announcement on the implementation of the third batch of Medical Devices UDI (Draft for Comments)…
« Prev...2...678910...141618...Next »
Twitter Linkedin
United States
Email: info@bradyknowsmedical.com
Phone: +86 18600392020
China
Beijing Office: Room 1501-1502, East Ocean Centre, No. 24 A, Jianguomenwai Avenue, Chaoyang District, Beijing, China
Shanghai Office: Lingang New Zone, China (Shanghai) Pilot Free Trade Zone
Hainan Office: Boao Lecheng pilot zone of international medical tourism, Qionghai City, Hainan Province
Email: info@bradyknowsmedical.com
Phone: +86 18600392020 +86 10 65155991

©2025 Bradynuoen Beijing PharmTech Co Ltd All Rights Reserved.

京ICP备15042665号-7